Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-09-25
2007-09-25
Morris, Patricia L. (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S342000, C514S365000, C546S124000, C546S270400, C548S200000
Reexamination Certificate
active
10731854
ABSTRACT:
Novel 2-arylthiazole derivatives of Formula I are described which are openers of KCNQ potassium channels and are useful in the treatment of disorders that are responsive to the opening of the KCNQ potassium channels, including pain and migraine
REFERENCES:
patent: 3689481 (1972-09-01), Scheuermann et al.
patent: 3794636 (1974-02-01), Girgis
patent: 3872124 (1975-03-01), LeMartret et al.
patent: 4923886 (1990-05-01), Shiokawa et al.
patent: 4980363 (1990-12-01), Shimotori et al.
patent: 5057142 (1991-10-01), Baasner et al.
patent: 5244867 (1993-09-01), Ditrich et al.
patent: 5614520 (1997-03-01), Kondo et al.
patent: 5846990 (1998-12-01), Murugesan et al.
patent: 5859035 (1999-01-01), Anthony et al.
patent: 5888941 (1999-03-01), Bartroli et al.
patent: 5998450 (1999-12-01), Eicken et al.
patent: 6518290 (2003-02-01), Sierra
patent: 57183768 (1982-11-01), None
patent: 01250379 (1989-10-01), None
patent: 02229190 (1990-09-01), None
patent: 04049290 (1992-02-01), None
patent: 4-128275 (1992-04-01), None
patent: 128275 (1992-04-01), None
patent: 04128275 (1992-04-01), None
patent: WO 95/19972 (1995-07-01), None
patent: WO 98/28282 (1998-07-01), None
patent: WO 99/59570 (1999-11-01), None
patent: WO 99/66925 (1999-12-01), None
patent: WO 00/06085 (2000-02-01), None
patent: WO 01/10798 (2001-02-01), None
patent: WO 01/40207 (2001-06-01), None
H.-S. Wang, et al, “KCNQ2 and KCNQ3 Potassium Channel Subunits: Molecular Correlates of the M-Channel,” Science, 282, pp. 1890-1893, 1998.
Boy Kenneth M.
Guernon Jason M.
Wu Yong-Jin
Bristol--Myers Squibb Company
Epperson James
Morris Patricia L.
LandOfFree
2-aryl thiazole derivatives as KCNQ modulators does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2-aryl thiazole derivatives as KCNQ modulators, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2-aryl thiazole derivatives as KCNQ modulators will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3782986